SCHEMBL23258512

SCHEMBL23258512

O=c1c(Br)ccccc1OCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.52
▸ L3MBTL1 Q9Y468 2/20 0.52
▸ MAPT P10636 3/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ MAPK14 Q16539 3/20 0.49
▸ ALPG P10696 1/20 0.49
▸ PTK2B Q14289 1/20 0.49
▸ HTR1A P08908 1/20 0.49
▸ DRD2 P14416 1/20 0.49
▸ CCNB2 O95067 1/20 0.47
▸ CDK1 P06493 1/20 0.47
▸ CDK4 P11802 1/20 0.47
▸ CCNB1 P14635 1/20 0.47
▸ CCND1 P24385 1/20 0.47
▸ CCNB3 Q8WWL7 1/20 0.47
▸ LIPE Q05469 1/20 0.47
▸ LTA4H P09960 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1081189 0.84 MAPT (0.59) TDP1L3MBTL1MAPTMAPK1MAPK14
SCHEMBL29414783 0.84 MAPT (0.59) TDP1L3MBTL1MAPTMAPK1MAPK14
SCHEMBL23258912 0.84 FFAR1 (0.49) TDP1L3MBTL1MAPTMAPK1MAPK14
Formaldehyde SCHEMBL27880496 0.83 MAPT (0.54) TDP1L3MBTL1MAPTMAPK1MAPK14
SCHEMBL1513408 0.82 MAPT (0.57) TDP1L3MBTL1MAPTMAPK1MAPK14
SCHEMBL23258713 0.80 PTGER1 (0.48) TDP1L3MBTL1MAPTMAPK1MAPK14
SCHEMBL23259170 0.80 MAPT (0.47) TDP1L3MBTL1MAPTMAPK1MAPK14
SCHEMBL16921617 0.80 MAPK14 (0.44) TDP1L3MBTL1MAPTMAPK1MAPK14
SCHEMBL18171750 0.79 TDP1 (0.58) TDP1L3MBTL1MAPTMAPK1MAPK14
SCHEMBL23258900 0.78 L3MBTL1 (0.52) TDP1L3MBTL1MAPTMAPK1MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018105-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS KINESID THERAPEUTICS, INC. (US) 2024-01-18 — — US disclosed
US-20240018105-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS KINESID THERAPEUTICS, INC. (US) 2024-01-18 — — US disclosed
US-20230406803-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS Kinesid Therapeutics, Inc (US) 2023-12-21 — — US disclosed
EP-4045477-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS Ambys Medicines, Inc. (US) 2022-08-24 — — EP disclosed
WO-2021076938-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS Ambys Medicines, Inc. (US) 2021-04-22 — — WO disclosed
WO-2021076945-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS Ambys Medicines, Inc. (US) 2021-04-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018105-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS TXNRD2, TXNRD1, SDHB TDP1 503/4885L3MBTL1 2606/4885MAPT 43/4885
US-20230406803-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS TXNRD2, TFRC, SDHB TDP1 652/4885L3MBTL1 3216/4885MAPT 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback